Literature DB >> 7696247

Intravitreal chemotherapy for recurrent retinoblastoma in an only eye.

S Seregard, E Kock, E af Trampe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7696247      PMCID： PMC505058          DOI： 10.1136/bjo.79.2.194

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  4 in total

1.  Present therapeutic resources in retinoblastoma.

Authors:  L A ERICSON; B H ROSENGREN
Journal:  Acta Ophthalmol (Copenh)       Date:  1961

2.  Local extraocular extension of retinoblastoma following intraocular surgery.

Authors:  K E Stevenson; J Hungerford; A Garner
Journal:  Br J Ophthalmol       Date:  1989-09       Impact factor: 4.638

3.  Trials of intravitreal injections of chemotherapeutic agents in rabbits.

Authors:  L Ericson; B Karlberg; B H Rosengren
Journal:  Acta Ophthalmol (Copenh)       Date:  1964

4.  Plaque radiotherapy in the management of retinoblastoma. Use as a primary and secondary treatment.

Authors:  C L Shields; J A Shields; P De Potter; S Minelli; C Hernandez; L W Brady; J R Cater
Journal:  Ophthalmology       Date:  1993-02       Impact factor: 12.079
  4 in total
  14 in total

Review 1.  Chemotherapy for retinoblastoma: a current topic.

Authors:  P T Finger; G Czechonska; H Demirci; A Rausen
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

2.  Retinoblastoma. Fifty years of progress. The LXXI Edward Jackson Memorial Lecture.

Authors:  Hans E Grossniklaus
Journal:  Am J Ophthalmol       Date:  2014-07-24       Impact factor: 5.258

Review 3.  Management of retinoblastoma in children: current status.

Authors:  Guillermo Chantada; Paula Schaiquevich
Journal:  Paediatr Drugs       Date:  2015-06       Impact factor: 3.022

4.  Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma.

Authors:  M D de Smet; V S Vancs; D Kohler; D Solomon; C C Chan
Journal:  Br J Ophthalmol       Date:  1999-04       Impact factor: 4.638

5.  Vitreous Disease in Retinoblastoma: Clinical Findings and Treatment.

Authors:  Jasmine H Francis; Larissa A Habib; David H Abramson
Journal:  Adv Ophthalmol Optom       Date:  2017-08

Review 6.  The management of retinoblastoma.

Authors:  Ido D Fabian; Zerrin Onadim; Esin Karaa; Catriona Duncan; Tanzina Chowdhury; Irene Scheimberg; Shin-Ichi Ohnuma; M Ashwin Reddy; Mandeep S Sagoo
Journal:  Oncogene       Date:  2018-01-11       Impact factor: 9.867

7.  Intravitreal chemotherapy in retinoblastoma: expanded use beyond intravitreal seeds.

Authors:  David H Abramson; Xunda Ji; Jasmine H Francis; Federica Catalanotti; Scott E Brodie; Larissa Habib
Journal:  Br J Ophthalmol       Date:  2018-06-06       Impact factor: 4.638

8.  Potential of Aqueous Humor as a Surrogate Tumor Biopsy for Retinoblastoma.

Authors:  Jesse L Berry; Liya Xu; A Linn Murphree; Subramanian Krishnan; Kevin Stachelek; Emily Zolfaghari; Kathleen McGovern; Thomas C Lee; Anders Carlsson; Peter Kuhn; Jonathan W Kim; David Cobrinik; James Hicks
Journal:  JAMA Ophthalmol       Date:  2017-11-01       Impact factor: 7.389

Review 9.  Focal laser treatment in addition to chemotherapy for retinoblastoma.

Authors:  Ido D Fabian; Kenneth P Johnson; Andrew W Stacey; Mandeep S Sagoo; M A Reddy
Journal:  Cochrane Database Syst Rev       Date:  2017-06-07

10.  Effects of single, short-term exposures of human retinal pigment epithelial cells to thiotepa or 5-fluorouracil: implications for the treatment of proliferative vitreoretinopathy.

Authors:  C H Kon; N L Occleston; A Foss; C Sheridan; G W Aylward; P T Khaw
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.